Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Rite Aid Corporation
  6. News
  7. Summary
    RAD   US7677548726

RITE AID CORPORATION

(RAD)
  Report
Delayed Nyse  -  04:00 2022-08-08 pm EDT
9.090 USD   +1.11%
08/04Rite Aid Opens Online Scheduling for Flu Vaccines at All Locations
BU
07/29Rite Aid Shares Surge Amid Heavy Volume After Reelection of Board Members
MT
07/29RITE AID COULD BE SUBJECT TO ACTIVIST INTEREST : Dealreporter
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Rite Aid to Start Administering Pfizer's Booster Shot to Chidren Ages 5 to 11

05/20/2022 | 01:16pm EDT
share with twitter
share with LinkedIn
share with facebook


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
PFIZER, INC. 0.61% 49.57 Delayed Quote.-16.56%
RITE AID CORPORATION 1.11% 9.09 Delayed Quote.-38.80%
All news about RITE AID CORPORATION
08/04Rite Aid Opens Online Scheduling for Flu Vaccines at All Locations
BU
07/29Rite Aid Shares Surge Amid Heavy Volume After Reelection of Board Members
MT
07/29RITE AID COULD BE SUBJECT TO ACTIVIS : Dealreporter
MT
07/28RITE AID CORP : Change in Directors or Principal Officers, Submission of Matters to a Vote..
AQ
07/28Declaration of voting results by Rite Aid Corporation
CI
07/20Rite Aid Releases Fourth Annual Environmental, Social and Governance Report
BU
07/20RITE AID : Sustainability Report - 2022
PU
07/19Rite Aid, Quest Diagnostics to Provide Access to COVID-19 PCR Testing
MT
07/19Rite Aid and Quest Diagnostics Expand Access to COVID-19 PCR Testing Nationwide
BU
07/13Rite Aid Opens New Modern Headquarters in Philadelphia's Navy Yard
BU
More news
Analyst Recommendations on RITE AID CORPORATION
More recommendations
Financials (USD)
Sales 2023 23 753 M - -
Net income 2023 -224 M - -
Net Debt 2023 2 660 M - -
P/E ratio 2023 -2,21x
Yield 2023 -
Capitalization 506 M 506 M -
EV / Sales 2023 0,13x
EV / Sales 2024 0,14x
Nbr of Employees 53 000
Free-Float 96,0%
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBullishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 3
Last Close Price 9,09 $
Average target price 6,33 $
Spread / Average Target -30,3%
EPS Revisions
Managers and Directors
Heyward R. Donigan President, Chief Executive Officer & Director
Matthew C. Schroeder Chief Financial Officer & Executive Vice President
Bruce G. Bodaken Chairman
Justin Mennen Chief Digital & Technology Officer
Arun Nayar Independent Director
Sector and Competitors
1st jan.Capi. (M$)
RITE AID CORPORATION-38.80%506
RAIA DROGASIL S.A.-8.64%7 018
AIN HOLDINGS INC.32.29%1 967
PETMED EXPRESS, INC.-15.48%432
QOL HOLDINGS CO., LTD.3.93%396
HLS THERAPEUTICS INC.-15.27%319